Loading cancer entity…
Loading cancer entity…
Clinical trials
38 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04915144 | 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs | withdrawn | Phase 2 | 0 | British Columbia Cancer AgencyOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT03053284 | Pasireotide in Hyperinsulinemic Hypoglycemia | withdrawn | Phase 2 | 0 | Montefiore Medical CenterOTHER | 0 | May 14, 2021 | clinicaltrials |
| NCT02108782 |
| Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors |
| withdrawn |
| Phase 2 |
| 0 |
| Academic and Community Cancer Research UnitedOTHER |
| 0 |
| Jul 19, 2017 |
| clinicaltrials |
Data updated 22 days agoSource updated Feb 21, 2023source: clinicaltrials